Mengchao Wu Selected Research

Mengchao Wu Research Topics

Disease

88	Neoplasms (Cancer) 01/2021 - 01/2002
72	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 01/2002
19	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2002
15	Liver Neoplasms (Liver Cancer) 12/2022 - 02/2002
12	Carcinogenesis 01/2019 - 09/2008
11	Hypoxia (Hypoxemia) 03/2013 - 09/2002
8	Infections 01/2018 - 06/2002
7	Cholangiocarcinoma 01/2021 - 09/2004
7	Fibrosis (Cirrhosis) 08/2016 - 09/2008
6	Hepatitis B 12/2019 - 01/2006
5	Thrombosis (Thrombus) 01/2018 - 11/2010
5	Starvation 01/2016 - 12/2011
5	Carcinoma (Carcinomatosis) 08/2015 - 09/2004
4	Chronic Hepatitis B 12/2019 - 04/2012
4	Hemorrhage 02/2016 - 12/2010
4	Liver Cirrhosis (Hepatic Cirrhosis) 04/2014 - 09/2011
3	Inflammation (Inflammations) 01/2018 - 11/2008
3	Circulating Neoplastic Cells 01/2016 - 01/2013
3	Liver Diseases (Liver Disease) 02/2015 - 03/2011
2	Gallbladder Neoplasms (Gallbladder Cancer) 08/2015 - 12/2011
2	Lymphatic Metastasis 03/2013 - 04/2010
2	Lung Neoplasms (Lung Cancer) 06/2009 - 05/2009
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2017
1	Hepatitis 08/2016

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 10/2016 - 01/2002
10	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2011
10	Small Interfering RNA (siRNA)IBA 01/2016 - 06/2005
10	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2008 - 08/2004
8	Biomarkers (Surrogate Marker)IBA 12/2019 - 07/2011
7	Messenger RNA (mRNA)IBA 01/2020 - 06/2008
5	Antiviral Agents (Antivirals)IBA 05/2019 - 02/2015
5	CytokinesIBA 01/2018 - 07/2011
5	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2015 - 09/2004
5	SurvivinIBA 08/2015 - 11/2002
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2015 - 09/2002
5	Therapeutic UsesIBA 04/2014 - 06/2002
5	AntigensIBA 06/2013 - 06/2007
4	Capsules (Microcapsules)IBA 01/2019 - 01/2013
4	LigandsIBA 01/2018 - 06/2007
4	DNA (Deoxyribonucleic Acid)IBA 04/2016 - 12/2002
4	Fetal Proteins (Fetoprotein)IBA 04/2016 - 07/2011
4	CateninsIBA 08/2015 - 09/2012
4	Complementary DNA (cDNA)IBA 02/2012 - 02/2002
3	Long Noncoding RNAIBA 01/2020 - 01/2016
3	Oncogene Proteins (Oncogene Protein)IBA 02/2015 - 06/2005
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 02/2014 - 04/2010
3	EndostatinsIBA 04/2008 - 08/2004
3	Fluorouracil (Carac)FDA LinkGeneric 11/2007 - 07/2006
2	Sorafenib (BAY 43-9006)FDA Link 02/2019 - 01/2016
2	Sirolimus (Rapamycin)FDA Link 01/2016 - 03/2008
2	Interleukin-1 Receptor-Associated KinasesIBA 01/2016 - 02/2015
2	mirdametinibIBA 01/2014 - 09/2012
2	Chir 99021IBA 01/2014 - 09/2012
2	CarcinogensIBA 09/2013 - 06/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2013 - 08/2011
2	Glucose (Dextrose)FDA LinkGeneric 08/2013 - 01/2013
2	ChemokinesIBA 03/2013 - 10/2008
2	Oxygen (Dioxygen)IBA 03/2013 - 11/2011
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2012 - 11/2009
2	Beclin-1IBA 11/2011 - 11/2009
2	Transcription Factors (Transcription Factor)IBA 08/2011 - 06/2009
2	Cisplatin (Platino)FDA LinkGeneric 04/2011 - 10/2008
2	Chemokine ReceptorsIBA 11/2010 - 10/2008
2	Cyclin D1IBA 11/2009 - 06/2009
2	Tumor Suppressor Protein p14ARF (p14ARF)IBA 11/2008 - 11/2002
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2008 - 06/2008
2	OsteopontinIBA 09/2008 - 07/2008
2	Interleukin-12 (IL 12)IBA 08/2002 - 04/2002
2	dl1520 (ONYX-015)IBA 08/2002 - 04/2002
1	alpha-L-Fucosidase (Fucosidase)IBA 01/2019
1	CC ChemokinesIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2018
1	HMGB1 Protein (HMG1)IBA 01/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2017
1	Neuraminidase (Sialidase)IBA 10/2016
1	LipidsIBA 10/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2016
1	EnzymesIBA 10/2016
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2016
1	TransferasesIBA 08/2016
1	Untranslated RNA (Noncoding RNA)IBA 04/2016
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2016
1	Heat Shock Transcription FactorsIBA 01/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016

Therapy/Procedure

28	Therapeutics 01/2019 - 01/2002
18	Hepatectomy 01/2021 - 05/2002
10	Drug Therapy (Chemotherapy) 01/2016 - 10/2007
4	Radiotherapy 01/2012 - 11/2002
3	Immunotherapy 12/2022 - 02/2012
2	Radiofrequency Ablation 01/2020 - 11/2002
2	Liver Transplantation 01/2016 - 07/2009
2	Pancreaticoduodenectomy 06/2014 - 03/2007
2	Lasers (Laser) 04/2012 - 01/2006
2	Biological Therapy 03/2011 - 06/2008
2	Injections 01/2011 - 11/2008
2	Chemoprevention 11/2009 - 06/2009
1	Contraindications 01/2018